Thoracentesis QI Study

November 3, 2023 updated by: University of Minnesota

Thoracentesis Quality Improvement (QI) Study

Researchers will compare 3 standard of care methods of pleural fluid drainage during therapeutic thoracentesis. Patients are randomized to manual aspiration, vacuum bottle drainage or wall suction methods. Primary outcome is procedural time with secondary outcomes of pain and dyspnea scores.

Study Overview

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age >18
  • Evidence of pleural effusion on imaging
  • Clinical indication for thoracentesis

Exclusion Criteria:

  • Age <18
  • Standard contraindication for thoracentesis procedure
  • Patients on positive pressure ventilation
  • Patients who have opted out of research in EPIC

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Manual aspiration
pleural fluid is drained using a standard thoracentesis kit and via a syringe and three-way stopcock
One option from standard of care
Active Comparator: Wall suction
pleural fluid is drained using a standard thoracentesis kit and by attaching tubing to wall suctioning set at -50 mmHg continuously
One option from standard of care
Active Comparator: Vacuum bottle drainage
pleural fluid is drained using a standard thoracentesis kit and tubing that attaches to a glass vacuum container
One option from standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Procedural time to 500mL
Time Frame: Through study completion, an average of 24 hours
Time to pleural fluid drainage from initiation of therapeutic drainage to 500mL
Through study completion, an average of 24 hours
Procedural time to 750mL
Time Frame: Through study completion, an average of 24 hours
Time to pleural fluid drainage from initiation of therapeutic drainage to 750mL
Through study completion, an average of 24 hours
Procedural time to 1L
Time Frame: Through study completion, an average of 24 hours
Time to pleural fluid drainage from initiation of therapeutic drainage to 1L
Through study completion, an average of 24 hours
Pain and dyspnea scores- Baseline
Time Frame: Immediately prior to starting the thoracentesis
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
Immediately prior to starting the thoracentesis
Pain and dyspnea scores- Cath
Time Frame: Through study completion, an average of 24 hours
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
Through study completion, an average of 24 hours
Pain and dyspnea scores- Post-fluid
Time Frame: Through study completion, an average of 24 hours
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
Through study completion, an average of 24 hours
Pain and dyspnea scores- Post-cath
Time Frame: Immediately after removing the thoracentesis catheter
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
Immediately after removing the thoracentesis catheter
Pain and dyspnea scores- 5m post
Time Frame: 5 minutes post-procedure
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
5 minutes post-procedure
Pain and dyspnea scores- 24h post
Time Frame: 24 hours post-procedure
Patients will be asked to indicate their pain and dyspnea level verbally using the Modified Borg Scale for Dyspnea and Numerical Ratings Scale (0-10, with 10 being highest level of pain)
24 hours post-procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roy Cho, MD, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

April 25, 2022

First Submitted That Met QC Criteria

June 14, 2022

First Posted (Actual)

June 21, 2022

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

November 3, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pleural Effusion

Clinical Trials on Manual aspiration

3
Subscribe